Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,182.9
3.5 (0.11%)

 

  • STI Straits Times Index
    3,182.9
    3.5 (0.11%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,599.6
    1.3 (0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,900.8
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,416.7
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,729.2
    108.2 (0.37%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,050.3
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 207.6M
  • Value: 130.1M
  • Rise: 96
  • Fall: 56
  • Unch: 618

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.199+0.002
P5 Capital0.039+0.001
Jiutian Chemical0.100-0.001
Rex Intl0.184+0.001
Anchor Resources0.031-
Oceanus^0.041-0.001
Ntegrator Intl0.014-
MM2 Asia0.058-0.001
CWX Global0.004-0.001
CromwellReit EUR0.470+0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,857.8 -138.3
HSI 28,788.2 -112.7
HSCEI 10,938.5 -60.8
Jakarta 6,050.3
Nikkei 225 29,712.4 +91.4
SSE Comp 3,400.1 -16.6
Shanghai A 3,563.8 -17.4
Shanghai B 246.0
KOSPI 3,195.0 +12.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CHIMERIC THERAPEUTICS LTD CHIMERIC THERAPEUTICS
Updated on 14 Apr 2021 (End of trading day)
Last (AUD): 0.305 Change: +0.015 High: 0.305 Remarks: -
Change (%): +5.17 Low: 0.290
Open 0.295 Yesterday's Close 0.29
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 710,532 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.00019 Trailing EPS (AUD) e -0.00019 NAV (AUD) b -0.0078
PE a - Trailing PE f - Price / NAV b -39.1026
Dividend (AUD) d - Cash In Hand (AUD) g 0.0002 Issued & Paid-up Shares c 330,526,000
Dividend Yield (%) d - Price / Cash In Hand g 1,525.000 Treasury Shares h -
Beta - 75 Daysi 0.856 R-Squared - 75 Days(%)i 0.11 Market Cap (M) 100.810
Beta - 500 Daysi 2.903 R-Squared - 500 Days (%)i 0.35 Enterprise Value (M) 105.612
Piotroski F Score - Exchange Code CHM Par Value ( AUD ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 75.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 Jan 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 11 Jan 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CHIMERIC THERAPEUTICS LTD ASX 100.810 - - -39.1026 -
Industry Biotechnology ASX 3,314.371 46.227 37.934 10.7512 1.033
Local Peer CSL LTD ASX 121,881.136 38.861 32.025 11.5338 1.096
Local Peer POLYNOVO LIMITED ASX 2,070.144 - - 93.9940 -
Local Peer MESOBLAST LTD ASX 1,477.697 - - 2.1982 -
Local Peer TELIX PHARMACEUTIC ASX 1,142.374 - - 14.4587 -
Local Peer IMUGENE LIMITED ASX 810.164 - - 12.8788 -
Local Peer ANTEOTECH LIMITED ASX 534.101 - - 86.3636 -
Local Peer OPTHEA LIMITED ASX 545.821 - - 2.7626 -
Local Peer IMMUTEP LTD ASX 305.923 - - 5.0388 -
Local Peer NEXT SCIENCE LTD ASX 317.746 - - 12.9674 -
Local Peer KAZIA THERAPEUTICS LIMITED ASX 203.799 - - 6.4323 -
Local Peer BIONOMICS LTD ASX 190.701 - - 11.8750 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 158.771 - - 6.5598 -
Other Local Peers LEAF RESOURCES LTD (ASX), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), MEMPHASYS LTD (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), BIOTRON (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), CRYOSITE (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 143,921.710 19.813 19.813 15.2962 2.572
Global Peer GILEAD SCIENCES INC NASDAQ 81,540.774 662.955 662.933 4.4798 4.183
Global Peer MODERNA INC NASDAQ 64,040.805 - - 25.0023 -
Global Peer ILLUMINA INC NASDAQ 58,819.585 89.664 89.664 12.5308 -
Global Peer WUXI BIO HKEx 445,987.347 235.002 235.004 18.2916 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,889.807 20.611 20.611 6.4339 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 51,106.235 14.547 14.547 4.6354 -
Global Peer BIOGEN INC NASDAQ 40,076.235 10.018 10.018 3.7453 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,306.822 56.856 56.856 2.9445 -
Global Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 31,310.782 1,807.333 1,807.226 18.6538 -
Other Global Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), SEAGEN INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), ZAI LAB-SB (HKEx), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), FATE THERAPEUTICS (NASDAQ), EXELIXIS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), JOINN (HKEx), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), Lonza (SGX), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), GENSCRIPT BIO (HKEx), VERACYTE INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), ARVINAS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), INSTIL BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), NUVATION BIO INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), 3SBIO (HKEx), MYRIAD GENETICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), FIBROGEN INC (NASDAQ), MACROGENICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VIVA BIOTECH (HKEx), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), JACOBIO-B (HKEx), JW THERAP-B (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), KINTOR PHARMA-B (HKEx), UNIQURE N.V. (NASDAQ), BIOATLA INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ALLOVIR INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), PRECIGEN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), HAOHAI BIOTEC (HKEx), REPLIMUNE GROUP INC (NASDAQ), ALECTOR INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), ALPHAMAB-B (HKEx), CARA THERAPEUTICS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), FRONTAGE (HKEx), OCUGEN INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), NKARTA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), VOR BIOPHARMA INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CURIS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PERSONALIS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ASCENTAGE-B (HKEx), ENANTA PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), JHBP-B (HKEx), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), HUMANIGEN INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), PASSAGE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), EPIZYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), IMMATICS N V (NASDAQ), ARDELYX INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VAXART INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), KADMON HLDGS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), MEIRAGTX HOLDINGS PLC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), IVERIC BIO INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), SINOMAB BIO-B (HKEx), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DPHARMA (Bursa), AKOUOS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LEE'S PHARM (HKEx), JOUNCE THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ATRECA INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), XOMA CORP (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ESSEX BIO-TECH (HKEx), HOMOLOGY MEDICINES INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), ASCLETIS-B (HKEx), ADICET BIO INC (NASDAQ), SESEN BIO INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), SPRUCE BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), ONCORUS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IMMUNOME INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), EIGER BIOPHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NEXTCURE INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), MEDICINOVA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), BIOVIE INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), EVOGENE LTD (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), INMUNE BIO INC (NASDAQ), CHIASMA INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), BIOMX INC (NYSE American), GAIN THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CEL-SCI CORP (NYSE American), SIO GENE THERAPIES INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), LONGEVERON INC (NASDAQ), IBIO INC (NYSE American), AZIYO BIOLOGICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ORGENESIS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), METACRINE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ARAVIVE INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), CIDARA THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), LEAP THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), RECRO PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), MERRIMACK PHARMACEUTICALS INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), AVALON GLOBOCARE CORP (NASDAQ), AIKIDO PHARMA INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), COHBAR INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VACCINEX INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), ATYR PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), IDERA PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), HISTOGEN INC (NASDAQ), ORAGENICS INC (NYSE American), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), PRECIPIO INC (NASDAQ), Suntar Eco-City (SGX), PHIO PHARMACEUTICALS CORP (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.020
+7.02 %
10 Days -+0.020
+7.02 %
20 Days --0.020
-6.15 %
Medium Term Return 3 Months -+0.190
+165.22 %
6 Months -+0.190
+165.22 %
1 Year -+0.190
+165.22 %
Long Term Return 2 Years -+0.190
+165.22 %
3 Years -+0.190
+165.22 %
5 Years -+0.190
+165.22 %
Annualised Return Annualised --
+21.54 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.275 - 0.440 Change From 1 Year Low +0.030 % Change From 1 Year Low (%) +10.91
Change From 1 Year High -0.135 % Change From 1 Year High (%) -30.68
2 Years Range 0.275 - 0.440 Change From 2 Years Low +0.030 % Change From 2 Years Low (%) +10.91
Change From 2 Years High -0.135 % Change From 2 Years High (%) -30.68
5 Years Range 0.275 - 0.440 Change From 5 Years Low +0.030 % Change From 5 Years Low (%) +10.91
Change From 5 Years High -0.135 % Change From 5 Years High (%) -30.68
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Chimeric Therapeutics Ltd. develops Chlorotixin CAR-T technology based cell therapies for the curation of solid tumors. Currently it is undergoing Phase 1 clinical trials at City of Hope in glioblastoma. The company was founded by Paul A. Hopper on Feburary 2, 2020 and is headquartered in Carlton South, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Apr 2021 0.295 0.305 0.290 0.305 710,532 -
13 Apr 2021 0.300 0.300 0.285 0.290 527,823 -
12 Apr 2021 0.300 0.310 0.295 0.295 1,298,961 -
09 Apr 2021 0.285 0.305 0.285 0.295 1,022,411 -
08 Apr 2021 0.285 0.290 0.285 0.285 630,239 -
07 Apr 2021 0.290 0.290 0.280 0.285 311,548 -
06 Apr 2021 0.290 0.300 0.285 0.285 645,748 -
01 Apr 2021 0.290 0.295 0.285 0.285 261,109 -
31 Mar 2021 0.285 0.290 0.275 0.285 948,332 -
30 Mar 2021 0.285 0.295 0.280 0.280 1,248,931 -
29 Mar 2021 0.285 0.290 0.280 0.285 566,728 -
26 Mar 2021 0.285 0.290 0.280 0.285 1,660,783 -
25 Mar 2021 0.295 0.305 0.285 0.285 1,360,226 -
24 Mar 2021 0.295 0.300 0.290 0.290 1,283,123 -
23 Mar 2021 0.300 0.310 0.280 0.295 2,162,848 -
22 Mar 2021 0.310 0.310 0.300 0.300 812,312 -
19 Mar 2021 0.310 0.310 0.295 0.310 1,091,723 -
18 Mar 2021 0.325 0.325 0.305 0.315 2,470,634 -
17 Mar 2021 0.305 0.325 0.305 0.325 1,417,939 -
16 Mar 2021 0.305 0.310 0.300 0.305 940,816 -
15 Mar 2021 0.310 0.310 0.290 0.305 1,375,632 -
12 Mar 2021 0.305 0.310 0.300 0.310 632,833 -
Summary
Current 2 Weeks
(30 Mar 2021 to 14 Apr 2021)
0.285 0.310 0.275 0.305 7,605,634 -
Previous 2 Weeks
(16 Mar 2021 to 29 Mar 2021)
0.305 0.310 0.275 0.285 13,767,132 -
4 Weeks from
(16 Feb 2021 to 15 Mar 2021)
0.295 0.310 0.275 0.305 36,167,828 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.